drugset / Trial / NCT01528124

A Study of LY3025876 in Healthy Volunteers

NCT01528124

Phase 1 Completed 41 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindBasic science

Summary

This trial is conducted in Singapore. The aim of this trial is to evaluate the safety and tolerability of the study drug in healthy people and investigate how much of the study drug gets into the blood stream and how long it takes the body to get rid of it. Information about any side effects that may occur will also be collected.

Timeline

Start
2012-02
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Subject LY3025876 Unknown Subcutaneous

Indications

No indication recorded.